Provided by Tiger Fintech (Singapore) Pte. Ltd.

Innoviva

21.69
+0.29001.36%
Post-market: 21.690.00000.00%16:20 EDT
Volume:1.42M
Turnover:30.80M
Market Cap:1.36B
PE:-22.74
High:21.93
Open:21.32
Low:21.22
Close:21.40
Loading ...

WEX, Lamb Weston, and More Stocks See Action From Activist Investors -- Barrons.com

Dow Jones
·
15 Mar

Armata Pharmaceuticals Enters $10 Million Secured Credit Agreement with Innoviva

MT Newswires Live
·
13 Mar

Innoviva Initiated at Sector Outperform by Scotiabank

Dow Jones
·
08 Mar

Innoviva initiated with an Outperform at Scotiabank

TIPRANKS
·
07 Mar

Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference

Business Wire
·
05 Mar

Innoviva Full Year 2024 Earnings: EPS: US$0.37 (vs US$2.75 in FY 2023)

Simply Wall St.
·
28 Feb

Innoviva Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
27 Feb

Innoviva Q4 EPS $0.26 Misses $0.37 Estimate, Sales $91.81M Beat $86.80M Estimate

Benzinga
·
27 Feb

Innoviva: Q4 Earnings Snapshot

Associated Press Finance
·
27 Feb

BRIEF-Innoviva Q4 EPS USD 0.26

Reuters
·
27 Feb

Innoviva Q4 Pretax Profit USD 24.694 Million

THOMSON REUTERS
·
27 Feb

Innoviva Q4 Basic EPS USD 0.32

THOMSON REUTERS
·
27 Feb

Innoviva's (NASDAQ:INVA) investors will be pleased with their 26% return over the last five years

Simply Wall St.
·
25 Dec 2024

Innoviva enters distribution, license agreement with Basilea for Zevtera

TipRanks
·
17 Dec 2024

Innoviva to Sell Basilea Pharmaceutica's MRSA Antibiotic Zevtera in US Under Exclusive Deal

MT Newswires Live
·
16 Dec 2024

BRIEF-Innoviva Specialty Therapeutics Signs Exclusive Distribution And Licensing Agreement To Acquire U.S. Marketing Rights For Zevtera®

Reuters
·
16 Dec 2024

Innoviva Inc: Under Agreement Terms, Basilea Will Receive $4 Mln Upfront Payment in Addition to Tiered Royalties and Milestones on Net Sales in U.S.

THOMSON REUTERS
·
16 Dec 2024

Innoviva Specialty Therapeutics Signs Exclusive Distribution and Licensing Agreement to Acquire U.S. Marketing Rights for Zevtera® (Ceftobiprole)

THOMSON REUTERS
·
16 Dec 2024

Innoviva Inc: Under Terms of Agreement, Innoviva, Inc., Will Be Granted Exclusive Marketing Rights to Zevtera in U.S.

THOMSON REUTERS
·
16 Dec 2024

Innoviva Inc: Innoviva Specialty Therapeutics Anticipates Commercializing Zevtera in Mid-Year 2025

THOMSON REUTERS
·
16 Dec 2024